» Articles » PMID: 30169455

Enteric Virome and Bacterial Microbiota in Children With Ulcerative Colitis and Crohn Disease

Overview
Publisher Wiley
Date 2018 Sep 1
PMID 30169455
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We examined the fecal virome and bacterial community composition of children with Crohn disease (CD), ulcerative colitis (UC), and healthy controls to test the hypothesis that unique patterns of viral organisms and/or presence of bacterial pathogens may be identified that could contribute to the pathogenesis of pediatric inflammatory bowel disease (IBD).

Methods: Fecal samples from 24 children (mean 12.2 years) with CD (n = 7) or UC (n = 5) and similar aged controls (n = 12) were processed to determine individual viromes. Viral sequences were identified through translated protein sequence similarity search. Bacterial microbiota were determined by sequencing of the V4 region of the 16S rRNA gene.

Results: Only a few human viruses were detected, so virome analyses focused on bacterial viruses. The relative abundance of Caudovirales was greater than that of Microviridae phages in both IBD and healthy controls. Caudovirales phages were more abundant in CD (mean 80.8%) than UC (48.8%) (P = 0.05) but not controls. The richness of viral strains in Microviridae but not Caudovirales was higher in controls than CD (P = 0.05) but not UC cases. No other measure of phage abundance, richness, or Shannon diversity showed significant difference between the 2 IBD and control groups. Bacterial microbiota analysis revealed that IBD diagnosis, albumin, hemoglobin, erythrocyte sedimentation rate, and probiotic supplementation correlated to the composition of gut bacterial microbiota.

Conclusions: Minor patterns in gut virome and bacterial community composition distinguish pediatric IBD patients from healthy controls. Probiotics are associated with bacterial microbiota composition. These exploratory results need confirmation in larger studies.

Citing Articles

The Role of Infant and Early Childhood Gut Virome in Immunity and the Triggering of Autoimmunity-A Narrative Review.

Mpakosi A, Sokou R, Theodoraki M, Iacovidou N, Cholevas V, Tsantes A Diagnostics (Basel). 2025; 15(4).

PMID: 40002565 PMC: 11854275. DOI: 10.3390/diagnostics15040413.


Omic characterizing and targeting gut dysbiosis in children with autism spectrum disorder: symptom alleviation through combined probiotic and medium-carbohydrate diet intervention - a pilot study.

Li Y, Hu W, Lin B, Ma T, Zhang Z, Hu W Gut Microbes. 2024; 16(1):2434675.

PMID: 39632378 PMC: 11622613. DOI: 10.1080/19490976.2024.2434675.


A single-stranded based library preparation method for virome characterization.

Zhai X, Gobbi A, Kot W, Krych L, Nielsen D, Deng L Microbiome. 2024; 12(1):219.

PMID: 39449043 PMC: 11515303. DOI: 10.1186/s40168-024-01935-5.


Recruitment of complete crAss-like phage genomes reveals their presence in chicken viromes, few human-specific phages, and lack of universal detection.

Ramos-Barbero M, Gomez-Gomez C, Vique G, Sala-Comorera L, Rodriguez-Rubio L, Muniesa M ISME J. 2024; 18(1).

PMID: 39361891 PMC: 11475920. DOI: 10.1093/ismejo/wrae192.


The Role of Host Genetics and Intestinal Microbiota and Metabolome as a New Insight into IBD Pathogenesis.

Zakerska-Banaszak O, Zuraszek-Szymanska J, Eder P, Ladziak K, Slomski R, Skrzypczak-Zielinska M Int J Mol Sci. 2024; 25(17).

PMID: 39273536 PMC: 11394875. DOI: 10.3390/ijms25179589.


References
1.
Vindigni S, Zisman T, Suskind D, Damman C . The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol. 2016; 9(4):606-25. PMC: 4913337. DOI: 10.1177/1756283X16644242. View

2.
Jakobsen C, Paerregaard A, Munkholm P, Faerk J, Lange A, Andersen J . Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: A prospective population-based cohort study 2007-2009. Inflamm Bowel Dis. 2011; 17(12):2541-50. DOI: 10.1002/ibd.21654. View

3.
Kim D, Cheon J . Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. Immune Netw. 2017; 17(1):25-40. PMC: 5334120. DOI: 10.4110/in.2017.17.1.25. View

4.
Zhou M, He J, Shen Y, Zhang C, Wang J, Chen Y . New Frontiers in Genetics, Gut Microbiota, and Immunity: A Rosetta Stone for the Pathogenesis of Inflammatory Bowel Disease. Biomed Res Int. 2017; 2017:8201672. PMC: 5558637. DOI: 10.1155/2017/8201672. View

5.
Li L, Deng X, Mee E, Collot-Teixeira S, Anderson R, Schepelmann S . Comparing viral metagenomics methods using a highly multiplexed human viral pathogens reagent. J Virol Methods. 2014; 213:139-46. PMC: 4344864. DOI: 10.1016/j.jviromet.2014.12.002. View